Human Ovarian Cancer Lysates

Pricing
Normal Lysates:  $125/100 ug
Tumor Lysates:   $175/100 ug
Nor./Tum. set: $270.00 (10% off)
Discounts
2-8    Vials  10%
9-20  Vials  15%
>20   Vials  20%

Call, Fax, or Email Your Order!

Histologic types of ovarian cancer include the following:

Serous cystomas - Serous benign cystadenomas, Serous cystadenomas with proliferating activity of the epithelial cells and nuclear abnormalities but with no infiltrative destructive growth (low potential or borderline malignancy), Serous cystadenocarcinomas.

Mucinous cystomas - Mucinous benign cystadenomas, Mucinous cystadenomas with proliferating activity of the epithelial cells and nuclear abnormalities but with no infiltrative destructive growth (low potential or borderline malignancy), Mucinous cystadenocarcinomas.

Endometrioid tumors (similar to adenocarcinomas in the endometrium) - Endometrioid benign cysts, Endometrioid tumors with proliferating activity of the epithelial cells and nuclear abnormalities but with no infiltrative destructive growth (low malignant potential or borderline malignancy), Endometrioid adenocarcinomas.

Clear cell (mesonephroid) tumors - Benign clear cell tumors, Clear cell tumors with proliferating activity of the epithelial cells and nuclear abnormalities but with no infiltrative destructive growth (low malignant potential or borderline malignancy), Clear cell cystadenocarcinomas.

Human Ovarian Cancer Lysates

Catalog Number

Diagnosis

Grade

Stage

TNM

Sex

Age

T5-001

Ovarian carcinoma

n/a

n/a

n/a

F

74

T5-002

Ovarian serous cystadenoma

n/a

n/a

n/a

F

38

T5-003

Ovarian papillary adenocarcinoma

n/a

n/a

n/a

F

53

T5-004

Ovarian malignant granunosa cell

n/a

n/a

n/a

F

54

T5-005

Ovarian fibrosarcoma

2

n/a

n/a

F

49

T5-006

Ovarian papillary adenocarcinoma

n/a

n/a

n/a

F

73

T5-007

Ovarian papillary adenocarcinoma

n/a

n/a

n/a

F

52

T5-008

Ovarian papillary cystadenocarcinoma

n/a

n/a

n/a

F

53

T5-009

Ovarian papillary adenocarcinoma

n/a

n/a

n/a

F

41

T5-010

Ovarian papillary cystadenocarcinoma

n/a

n/a

n/a

F

32

T5-011

Ovarian papillary cystadenocarcinoma

n/a

n/a

n/a

F

50

T5-012

Ovarian mucinous cystadenocarcinoma

n/a

IIIb

n/a

F

54

T5-013

Ovarian fibrosarcoma

2

IIIc

T2N1M0

F

63

T5-014

Sertoli-Leydig cell tumor

2

II

T1cNxMx

F

59

T5-015

Ovarian papillary serous cystadenocarcinoma, moderately differentiated

2

Ib

T1bN0M0

F

52

T5-016

Ovarian papillary serous cystadenocarcinoma, moderately differentiated

2

IIc,

T2cN0M0

F

43

T5-017

Adenocarcinoma

2

IIIb

T3bN0M0

F

54

T5-018

Ovarian endometroid carcinoma, moderately differentiated

2

Ia

n/a

F

48

T5-019

Ovarian endometroid carcinoma, moderately differentiated

3

IIa

T2N0M0

F

49

T5-020

Ovarian endometroid carcinoma, moderately differentiated

2

IIIc

T2bN1M0

F

68

T5-021

Ovarian endometroid carcinoma, moderately differentiated

2

n/a

n/a

F

61

T5-022

Ovarian endometroid carcinoma, moderately differentiated

2

n/a

n/a

F

63

T5-023

Ovarian clear cell carcinoma, moderately differentiated

2

IIb

T2N0M0

F

38

T5-024

Ovarian clear cell carcinoma, poorly differentiated

3

Ia

T1aN0M0

F

39

T5-025

Ovarian clear cell carcinoma, poorly differentiated

3

III

T3NxMx

F

54

T5-026

Ovarian cystadenocarcinoma, moderately differentiated

2

Ic

T2N0Mx

F

52

T5-027

Ovarian cystadenocarcinoma, moderately differentiated

2

Ic

T2N0Mx

F

35

T5-028

Ovarian cystadenocarcinoma, moderately differentiated

2

III

T2N0Mx

F

45

T5-029

Ovarian cystadenocarcinoma, moderately differentiated

2

Ia

T2N0Mx

F

46

T5-030

Ovarian anaplastic carcinoma, poorly differentiated

3

Ic

T1N0Mx

F

44

T5-031

Ovarian dysgerminoma, poorly differentiated.

2

III

T3NxM1

F

17

T5-032

Ovarian dysgerminoma, poorly differentiated

2

Ia

T1N0Mx

F

17

T5-033

Ovarian fibrosarcoma, moderately differentiated

2

II

T2N0M0

F

76

T5-034

Ovarian Sertoli-Leydig cell tumor, poorly differentiated

3

n/a

n/a

F

63

T5-035

Ovarian adenocarcinoma, moderately differentiated.

2

IIa

T2N0Mx

F

50

T5-036

Ovarian adenocarcinoma, moderately differentiated.

2

IIIa

T3aN0M0

F

40

T5-037

Ovarian adenocarcinoma, poorly differentiated

3

IIc

T2cN0M0

F

15

T5-038

Ovarian adenocarcinoma, poorly differentiated

3

IIIc

T2aN1M0

F

44

T5-039

Ovarian adenocarcinoma, poorly differentiated

3

IIIc

n/a

F

50

T5-040

Ovarian adenocarcinoma, moderately differentiated

3

II,

T2N0M0

F

44

T5-042

Ovarian serous cystadenocarcinoma, moderately differentiated

2

Ib

T1N0Mx

F

47

T5-043

Ovarian serous cystadenocarcinoma, poorly differentiated

3

n/a

n/a

F

43

T5-044

Ovarian granulose cell carcinoma, moderately differentiated

2

IIIa

T3aN0M0

F

69

T5-045

Ovarian granulose cell carcinoma, moderately differentiated.

2

n/a

n/a

F

45

T5-046

Ovarian granulosa cell carcinoma, poorly differentiated

2

n/a

T1aN0M0

F

75

T5-047

Ovarian signet ring cell carcinoma, poorly differentiated

3

n/a

n/a

F

35

T5-048

Ovarian mature teratoma, poorly differentiated.

n/a

n/a

n/a

F

70

T5-049

Ovarian yolk sac tumor, poorly differentiated.

3

Ic

n/a

F

16

 

References:

Silverberg SG, Major FJ, Blessing JA, et al.: Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecologic Oncology Group pathologic study of 203 cases. Int J Gynecol Pathol 9 (1): 1-19, 1990.